| First-in-man experience with a new embolic deflection device in transcatheter aortic valve interventions. | |
| | |
MedLine Citation:
|
PMID: 22580248 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Aims: To report our first-in-man experience with a new cerebral embolic deflection device (SMT Embolic Deflection Device) during transcatheter aortic valve implantation (TAVI). A significant number of strokes and brain infarcts are caused by embolisation of atherosclerotic material, clots and other debris during various phases of invasive cardiac procedures, especially TAVI. The application of a temporary filter in the aortic arch averting dislodged emboli from entering the cerebral circulation might prevent this. Methods and results: In 15 patients (mean age 79 years) with severe aortic stenosis undergoing percutaneous transfemoral or transapical aortic valve implantation, the SMT Embolic Deflection Device was advanced utilising the contralateral femoral artery access using a 9 Fr delivery sheath. Once deployed in the aortic arch, a porous membrane shields the supraaortic-cerebral trunks by deflecting emboli away from the cerebral circulation. Embolic material is not contained or removed by the device. A 6 Fr pigtail catheter can be used through the same sheath throughout the whole procedure. Brain diffusion weighted (DW)-MRI was obtained in 10 patients before and at 4 days after (±2 days) the procedure and retrospectively compared to 20 patients previously undergoing TAVI without a protection device. Successful placement of the embolic protection device was achieved in all patients. Additional procedural time due to the use of the device was 7 min (±2 min). There were no procedural complications. No patient developed new neurological symptoms or clinical findings of stroke except one patient who suffered from a transient ischaemic attack (TIA) two days after the procedure. DW-MRI showed 3.2 new cerebral lesions per patient, compared to 7.2 new lesions per patient in the group without SMT filter. Conclusions: In this first-in-man experience, the feasibility of a new embolic deflection device is demonstrated. Larger randomised, prospective studies are required to confirm these findings and prove safety and efficacy by reducing the incidence of cerebral embolism and stroke after TAVI. |
| | |
Authors:
|
Kevin Onsea; Pierfrancesco Agostoni; Mariam Samim; Michiel Voskuil; Jolanda Kluin; Ricardo Budde; Jeroen Hendrikse; Faiz Ramjankhan; Jan van Klarenbosch; Pieter Doesburg; Gertjan Sieswerda; Pieter Stella |
Related Documents
:
|
22494778 - Risk of recurrent stroke before carotid endarterectomy: the ansyscap study. 21439768 - Comparison of clipping versus ligation of side-branches during saphenous vein graft har... 2783098 - Traumatic internal carotid artery aneurysm and massive epistaxis. 22422178 - Brain tissue oxygen monitoring to assess reperfusion after intra-arterial treatment of ... 2401918 - Modalities of origin of the middle cerebral artery. incidence on the arrangement of the... 12027198 - Monocyte chemoattractant protein-1 expression in intimal hyperplasia of vein grafts in ... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology Volume: 8 ISSN: 1969-6213 ISO Abbreviation: EuroIntervention Publication Date: 2012 May |
Date Detail:
|
Created Date: 2012-05-14 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101251040 Medline TA: EuroIntervention Country: France |
Other Details:
|
Languages: eng Pagination: 51-6 Citation Subset: IM |
Affiliation:
|
Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Implementation of primary angioplasty in Europe: Stent for Life initiative progress report.
Next Document: First experience with endovascular ultrasound renal denervation for the treatment of resistant hyper...